...
首页> 外文期刊>Pharmaceutical Biology >Co-expression of hepatitis C virus polytope–HBsAg and p19-silencing suppressor protein in tobacco leaves
【24h】

Co-expression of hepatitis C virus polytope–HBsAg and p19-silencing suppressor protein in tobacco leaves

机译:丙型肝炎病毒多表位– HBsAg和p19沉默抑制蛋白在烟草叶片中的共表达

获取原文

摘要

Abstract Context: Plants transformed by virus-based vectors have emerged as promising tools to rapidly express large amounts and inexpensive antigens in transient condition. Objective: We studied the possibility of transient-expression of an HBsAg-fused polytopic construct (HCVpc) [containing H-2d and HLA-A2-restricted CD8+CTL-epitopic peptides of C (Core; aa 132-142), E6 (Envelope2; aa 614-622), N (NS3; aa 1406-1415), and E4 (Envelope2; aa 405-414) in tandem of CE6NE4] in tobacco (Nicotiana tabacum) leaves for the development of a plant-based HCV vaccine. Materials and methods: A codon-optimized gene encoding the Kozak sequence, hexahistidine (6×His)-tag peptide, and HCVpc in tandem was designed, chemically synthesized, fused to HBsAg gene, and inserted into Potato virus X (PVX-GW) vector under the control of duplicated PVX coat protein promoter (CPP). The resulted recombinant plasmids (after confirmation by restriction and sequencing analyses) were transferred into Agrobacterium tumefaciens strain GV3101 and vacuum infiltrated into tobacco leaves. The effect of gene-silencing suppressor, p19 protein from tomato bushy stunt virus, on the expression yield of HCVpc–HBsAg was also evaluated by co-infiltration of a p19 expression vector. Results: Codon-optimized gene increased adaptation index (CAI) value (from 0.61 to 0.92) in tobacco. The expression of the HCVpc–HBsAg was confirmed by western blot and HBsAg-based detection ELISA on total extractable proteins of tobacco leaves. The expression level of the fusion protein was significantly higher in p19 co-agroinfiltrated plants. Discussion and conclusion: The results indicated the possibility of expression of HCVpc–HBsAg constructs with proper protein conformations in tobacco for final application as a plant-derived HCV vaccine.
机译:摘要背景:以病毒为基础的载体转化的植物已成为有希望的工具,可以在瞬时条件下快速表达大量廉价的抗原。目的:我们研究了瞬时表达HBsAg融合多聚体构建体(HCVpc)的可能性[包含H-2d和HLA-A2限制性C的CD8 + CTL-表位肽C(Core; aa 132-142),E6(烟草(Nicotiana tabacum)叶中的CE6NE4的Envelope2; aa 614-622),N(NS3; aa 1406-1415)和E4(Envelope2; aa 405-414)共同开发基于植物的HCV疫苗。材料和方法:设计密码子优化的基因,该基因编码串联的Kozak序列,六组氨酸(6×His)标签肽和HCVpc,化学合成,与HBsAg基因融合,并插入马铃薯X病毒(PVX-GW)载体在复制的PVX外壳蛋白启动子(CPP)的控制下。将得到的重组质粒(经限制性酶切和测序分析确认后)转移到根癌农杆菌GV3101菌株中,并真空渗入烟草叶中。还通过共渗入p19表达载体评估了基因沉默抑制物(来自番茄丛状特技病毒的p19蛋白)对HCVpc–HBsAg表达产量的影响。结果:密码子优化的基因提高了烟草的适应指数(CAI)值(从0.61到0.92)。通过Western blot和基于HBsAg的检测ELISA证实了HCVpc–HBsAg在烟叶中可提取的总蛋白上的表达。在p19共农杆菌浸润的植物中,融合蛋白的表达水平明显更高。讨论与结论:结果表明,在烟草中表达具有适当蛋白构象的HCVpc-HBsAg构建体的可能性最终可作为植物来源的HCV疫苗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号